The sixth most common principal diagnosis, sepsis, also takes the title as the most expensive inpatient diagnosis, racking up about $20 billion in hospitals’ aggregated annual costs. Sepsis isn’t ...

Procalcitonin, or PCT, screening on the first day of a patient intensive care unit’s admission appears to be a promising diagnostic tool for identifying sepsis, according to a new study in CHEST.

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with ...

New retrospective study in CHEST found procalcitonin testing at admission reduced the length of stay and total cost of care Each year, over $20 billion dollars is spent on sepsis care, making it the ...

Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections and sepsis. In this ...

A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...

A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous ...

A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) ...

A groundbreaking UK study in The Lancet has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in ...

A groundbreaking UK study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) ...